Fluloprazolam was first described in 1977 by Ager et al.
Pharmacology
Fluloprazolam is expected to have similar pharmacological properties as loprazolam. Its general level of activity has been described as "very high" alongside that of loprazolam. However, fluloprazolam’s dosing range and potency relative to other benzodiazepines has not been described in scientific literature.
Other pharmacological data on fluloprazolam is extremely limited. Little is known about its exact receptor targets, metabolism, and potential toxicity.
References
123Ager IR, Danswan GW, Harrison DR, Kay DP, Kennewell PD, Taylor JB (August 1977). "Central nervous system activity of a novel class of annelated 1,4-benzodiazepines, aminomethylene-2,4-dihydro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-ones". Journal of Medicinal Chemistry. 20 (8): 1035–1041. doi:10.1021/jm00218a009. PMID19630.
Notes
↑As compared to their parent compounds, which have no halogen on the phenyl group, and have a chlorine atom instead of a nitro group on the benzene ring; IUPAC name (2Z)-6-phenyl-2-[(4-methylpiperazin-1-yl)methylidene]-8-chloro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one.